De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy is a research paper published in Journal of the American Academy of Dermatology (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
CSRD VA
Grant: IK2 CX002452
NIGMS NIH HHS
Grant: T32 GM145449
NIDDK NIH HHS
Grant: F30 DK122712
FWCI
1.36
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals